REPCF:OTCMKTS
0913693 BC Ltd
$0.00010
0.00%
(0.00) 1D
Set 14, 9:39:46 AM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa REPCF...
Mkt. cap
7.36K
Avg. na dami
1.98K
Dami
0.00
P/E ratio
0.00
Mataas nang 52-wk
$0.00
Mababa nang 52-wk
$0.00
EPS
$0.09
Mga natitirang share
73.58M
Bilang ng mga empleyado
1
Mkt. cap
7.36K
Avg. na dami
1.98K
Dami
0.00
P/E ratio
0.00
Mataas nang 52-wk
$0.00
Mababa nang 52-wk
$0.00
EPS
$0.09
Mga natitirang share
73.58M
Bilang ng mga empleyado
1
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Yahoo Finance
·
2 oras ang nakalipas
S&P 500 alarm bells are starting to go off
Bloomberg.com
·
13 oras ang nakalipas
Stocks Under Pressure as Yields Offset AI Gains: Markets Wrap
Stocktwits
·
6 araw ang nakalipas
S&P 500, Dow, Nasdaq Futures Ease As Treasury Yields Continue To Spike — ORCL, META, AKAM, GOOGL, MGM In Focus
24/7 Wall St.
·
6 araw ang nakalipas
Wells Fargo Says the AI Spending Math Breaks in 2028 and Just Cut Its S&P 500 Target to 7,700
Profile
RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia. The company focuses on development of cell therapies using a patient's own cells. The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly, and hair restoration. The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle.
The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company. An alternative business model has been reported which does not involve acquisition but rather partnership where technologies and methods are licensed to a partner which will commercialize them. Wikipedia
Tungkol sa 0913693 BC Ltd
CEO-
Mga Empleyado1
Itinatag1967
HeadquartersVancouver, British Columbia, Canada
Sektor-
Websitereplicel.com